Delivery Order SPE2DB20D2014-SPE2DB25FC84C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) valued at $3,508.43. This contract utilizes a firm fixed-price structure with an ultimate completion date of September 26, 2025, and was awarded on a competitive basis without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count) with a ceiling value of $1,746.19. This firm fixed price delivery order, which is not set-aside and represents a competitively awarded contract, is scheduled for completion by July 25, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $1,461.60. The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, serving the Defense Logistics Agency's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180 count) under a firm fixed-price contract with a ceiling value of $20,034.76. The award, issued on September 29, 2025, represents a non-competitive delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.40 to AmerisourceBergen Drug Corp for Janumet XR 50-1,000 mg tablets (180 count) on January 22, 2025, with completion scheduled for January 23, 2025. This firm fixed price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 100-1,000 mg tablets (30-count) valued at $1,002.54. The contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This non-set-aside contract, valued at approximately $35,000, represents a firm fixed-price delivery order with an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count) in the amount of $1,908.41. The contract was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-competitive delivery order represents a firm fixed-price transaction under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $4,193.47 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC84CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $42,806.16. The delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this pharmaceutical supply obligation from its corporate office location in Conshohocken, Pennsylvania, serving the Defense Logistics Agency's medical supply chain requirements. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 vehicle extending through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains a substantial portfolio of federal medical procurement contracts covering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic categories. This particular delivery order for Janumet XR—a diabetes medication combining metformin and sitagliptin—reflects the company's ongoing role as a critical vendor supporting federal medical and military healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.8k | 8/26/25 |